Oct 23, 2026
Why Did Moderna Stock Crash 17% Despite Positive Cancer Vaccine Results?

The post Why Did Moderna Stock Crash 17% Despite Positive Cancer Vaccine Results? appeared first on Coinpedia Fintech News
Moderna stock suffered a sharp panic drop on Thursday, falling 17.57% to close at $202.63 despite promising results from its experimental personalized cancer vaccine. The sell-off followed the early publication of Phase 3 trial data for intismeran autogene, developed in partnership with Merck. The treatment demonstrated a meaningful reduction in melanoma recurrence risk, but investors …
Source: Coinpedia →Related News
- 3 hours ago
XRP Price Prediction: Bears Are Paying to Short XRP, A Short Squeeze?
- 4 hours ago
Are Bitcoin Whales Rotating Into Anthropic’s $61B IPO? Here’s Why BTC Is Under P...
- 9 hours ago
XRP Price Could Crash to $0.78 Before Its Next Major Rally: Here’s Why
- 12 hours ago
Bitcoin Price Plunges Below $65,000 – What’s Triggering the Massive Sell-off Acr...
- 12 hours ago
Gold and Silver Crash: Nearly $400 Billion Wiped Out as Prices Hit One-Year Lows
